Literature DB >> 24252564

Ability of body mass index to predict abnormal waist circumference: receiving operating characteristics analysis.

Márcio Weissheimer Lauria1, Lívia Maria Pinheiro Moreira, George Luiz Lins Machado-Coelho, Raimundo Marques do Nascimento Neto, Maria Marta Sarquis Soares, Adauto Versiani Ramos.   

Abstract

BACKGROUND: Body mass index (BMI) and waist circumference (WC) are the most used anthropometric measures to identify obesity. While BMI is considered to be a simple and accurate estimate of general adiposity, WC is an alternative surrogate measure of visceral obesity. However, WC is subject to significant inter-examiner variation. The aim of the present study was to correlate BMI and WC measures in a group of Brazilian adults to determine the most accurate BMI values for predicting abnormal WC.
METHODS: BMI and WC were measured in 1184 volunteers (45.6 ± 17.3 yrs; 69% female) using standard procedures. Abnormal WC was defined as ≥88 cm in women and ≥102 cm in men using the traditional criteria, and ≥80 cm in women and ≥90 cm in men using the new criteria. Statistical analysis involved the calculation of Pearson's correlation coefficients and receiver operating characteristic (ROC) curves.
RESULTS: BMI was strongly correlated with WC (women: r = 0.87, p < 0.0001, area under ROC curve = 0.93 ± 0.1; men: r = 0.89, p < 0.0001, area under ROC curve = 0.94 ± 0.01). The most accurate BMI cutoff point for abnormal WC was 27.1 kg/m2 for men and 26.8 kg/m2 for women using the traditional WC criteria, and 24.7 kg/m2 for men and 24.9 kg/m2 for women using the new WC criteria.
CONCLUSION: Based on the strong correlation found with WC, BMI can be used as the primary anthropometric measure to estimate adiposity, since both obese and most overweight subjects will have abnormal WC.

Entities:  

Year:  2013        PMID: 24252564      PMCID: PMC3918104          DOI: 10.1186/1758-5996-5-74

Source DB:  PubMed          Journal:  Diabetol Metab Syndr        ISSN: 1758-5996            Impact factor:   3.320


Background

Obesity is the fastest-growing chronic disease in both children and adults, and is becoming a global epidemic. In 2008, an estimated 1.5 billion adults worldwide were considered to be overweight or obese [1]. This public health concern is the cause of a number of comorbidities, being associated with high health care costs. Obesity is a risk factor for a variety of diseases, such as type 2 diabetes mellitus, cardiovascular disease, hypertension and cancer [2-4]. Overweight in adults is defined as a body mass index (BMI = weight in kilograms/height in meters squared) of 25.0 to 29.9 kg/m2, while obesity is defined as a BMI ≥ 30.0 kg/m2[5]. BMI was first described by Adolphus Quetelet in the mid- nineteenth century, based on the observation that body weight is proportional to height squared in adults with normal body frames [6]. BMI is widely employed as an anthropometric estimate of general adiposity. In recognition that visceral fat accumulation increases the risk of metabolic disease, waist circumference (WC) has been used as an alternative surrogate measure of obesity. Abnormal WC is traditionally defined as ≥88 cm in women and ≥102 cm in men, based on cutoff points advocated by Lean et al. in 1995 [7]. Recently, however, new cutoff points have been proposed for abnormal WC taking into consideration ethnic aspects. In South Americans, abnormal WC is defined as ≥80 cm in women and ≥90 cm in men. These values are based on the definition of metabolic syndrome by the International Diabetes Federation (IDF) [8]. However, while weight and height measurements are relatively simple and accurate, WC is subject to significant inter-examiner variation, which leads to concerns regarding its reliability. Furthermore, BMI has been described as a better predictor of cardiovascular events than WC in some studies [9-11]. The aim of the present study was to correlate BMI and WC in a group of Brazilian adults to determine the most accurate BMI values that best predict abnormal WC in men and women.

Methods

A total of 1184 subjects were consecutively evaluated and included in the present study. The volunteers spontaneously presented for a medical appointment at a general endocrine clinic at the Felício Rocho Hospital, Brazil, between March 2011 and February 2012. The exclusion criteria were the following: age < 18 yrs, history of abdominoplasty, history of solid organ transplant and chronic kidney disease. All the data were evaluated by physicians trained in measuring weight, height and WC using standard techniques. BMI was obtained from height and weight measurements with the subjects barefoot and wearing light clothing. A scale with accurate weighing up to 150 kg was used for weight determination. Height was measured to the nearest 1 cm using a stadiometer. For this measurement, the participants were positioned with heels, buttocks, shoulder blades and back of the head in contact with the backboard of the stadiometer and the top of the head in the Frankfort horizontal plane. BMI was calculated as weight in kilograms divided by height in meters squared (kg/m2). WC was measured with the subject in the standing position, at the end of exhalation, using a non-elastic measuring tape placed horizontally at the midpoint between the lowest rib and top of the iliac crest, as defined by the World Health Organization. Two different cutoff points were used for establishing abnormal WC: 1) ≥88 cm in women and ≥102 cm in men (traditional criteria); and 2) ≥ 80 cm in women and ≥90 cm in men (new criteria). The subjects were allocated into two groups (normal and abnormal) based on these two cutoff points. To estimate the most accurate BMI cutoff point for discriminating normal from abnormal WC, receiving operating characteristic (ROC) curves were constructed and separated by gender using both WC classification criteria. The point closest to the maximum sensitivity and specificity point was selected as the cutoff. Correlation analyses were performed between the BMI and WC using Pearson’s correlation coefficient (r) and area under ROC curves with 95% confidence interval {AUC (95% CI)}. An r value >0.7 indicated a strong correlation; r = 0.4 to 0.7 indicated a moderate correlation, and r <0.4 denoted a weak correlation. The Prism 4.0 software (Graph Pad, San Diego, CA, USA) was used for all analyses and a p value <0.05 was deemed statistically significant.

Results and discussion

Mean patient age was 45.6 ± 17.3 yrs. Women accounted for 69% of the sample. Mean BMI was 25.4 ± 4.8 kg/m2 for men and 27.1 ± 5.9 kg/m2 for women. Mean WC was 89.9 ± 14.4 cm for men and 88.9 ± 15.1 cm for women. Pearson’s correlation coefficient between BMI and WC was 0.89 for men (p < 0.0001) and 0.87 for women (p < 0.0001). The AUC (95% CI) between BMI and WC using the traditional classification was 0.94 (0.91-0.96) for men and 0.93 (0.91-0.95) for women (Figure 1). The AUC (95% CI) between BMI and WC using the new criteria was 0.95 (0.92-0.97) for men and 0.93 (0.91-0.94) for women (Figure 2).
Figure 1

ROC curve for prediction of central obesity (WC = 102 cm in men and 88 cm in women). (A) for men: cut-off value = 27.1 kg/m2 {sensitivity: 96%; specificity: 81%, AUC (95% CI) = 0.94 (0.91-0.96)} (B) for women: cut-off value = 26.8 kg/m2 {sensitivity: 82%; specificity: 89%, AUC (95% CI) = 0.93 (0.91-0.95)} AUC (95% CI) = area under ROC curves with 95% confidence interval; BMI-F = Body mass index in men, BMI-M = Body mass index in men.

Figure 2

ROC curve for prediction of central obesity (WC = 90 cm in men and 80 cm in women). (A) for men: cut-off value = 24.7 kg/m2 for men {sensitivity: 92%; specificity: 84%, AUC (95% CI) = 0.95 (0.92-0.97)}. (B) for women: cut-off value = 24.9 kg/m2 for women {sensitivity: 82%; specificity: 91%, AUC (95% CI) = 0.93 (0.91-0.94)}. AUC (95% CI) = area under ROC curves with 95% confidence interval; BMI-F = Body mass index in men, BMI-M = Body mass index in men.

ROC curve for prediction of central obesity (WC = 102 cm in men and 88 cm in women). (A) for men: cut-off value = 27.1 kg/m2 {sensitivity: 96%; specificity: 81%, AUC (95% CI) = 0.94 (0.91-0.96)} (B) for women: cut-off value = 26.8 kg/m2 {sensitivity: 82%; specificity: 89%, AUC (95% CI) = 0.93 (0.91-0.95)} AUC (95% CI) = area under ROC curves with 95% confidence interval; BMI-F = Body mass index in men, BMI-M = Body mass index in men. ROC curve for prediction of central obesity (WC = 90 cm in men and 80 cm in women). (A) for men: cut-off value = 24.7 kg/m2 for men {sensitivity: 92%; specificity: 84%, AUC (95% CI) = 0.95 (0.92-0.97)}. (B) for women: cut-off value = 24.9 kg/m2 for women {sensitivity: 82%; specificity: 91%, AUC (95% CI) = 0.93 (0.91-0.94)}. AUC (95% CI) = area under ROC curves with 95% confidence interval; BMI-F = Body mass index in men, BMI-M = Body mass index in men. The most accurate BMI cutoff point for abnormal WC was 27.1 kg/m2 for men (sensitivity: 96%; specificity: 81%) and 26.8 kg/m2 for women (sensitivity: 82%; specificity: 89%) using the traditional classification (Figure 1). Using the new criteria, the most accurate BMI cutoff point for abnormal WC was 24.7 kg/m2 for men (sensitivity: 92%; specificity: 84%) and 24.9 kg/m2 for women (sensitivity: 82%; specificity: 91%) (Figure 2). The present cross-sectional study with >1000 subjects demonstrated a strong correlation between BMI and WC in both genders. This study involved patients at ages ranging from 18 to 90 yrs. Moreover, no distinctions were made regarding ethnicity. In fact, considering the ethnic mix of the Brazilian population, the present findings may also apply to other populations. Strong correlation between BMI and WC (80-85%) has also been described in large cohorts [9,10]. Therefore, BMI provides a good estimation of WC in the majority of patients and can reasonably replace it, which is a very convenient feature in clinical practice. BMI is the most widely employed anthropometric measure, due in part to its convenience, safety and minimal cost. Several studies have related BMI to mortality and morbidity rates, thereby demonstrating that subjects with normal BMI or slightly overweight are in the lower risk group [12]. A recent meta-analysis found that obesity class 2 and 3 (BMI = 35–39.9 and ≥ 40 kg/m2, respectively) were significantly associated with increased overall mortality, while class 1 obesity (BMI = 30–34.9 kg/m2) was not associated with higher mortality rates and overweight was actually associated with significantly lower overall mortality rates [13]. On the other hand, using BMI alone for obesity assessment could be a limitation because it reflects both fat and lean mass and does not discriminate fat distribution [14]. Okorududu et al. conducted a systematic review of studies evaluating the performance of BMI in the detection of body adiposity and found that cutoff points for the diagnosis of obesity have high specificity but low sensitivity regarding the identification of adiposity, as half of the individuals with a high percentage of fat were not identified using this measure [15]. Moreover, BMI is particularly inaccurate in subjects with elevated lean body mass, such as athletes, and cannot be generalized among different ethnic groups. This measure is also criticized because it makes no difference between men and women [16]. WC, in turn, provides an estimation of abdominal fat and has been related to insulin resistance and cardiovascular risk. It is the cornerstone of the IDF definition of metabolic syndrome [8]. However, WC measurement is frequently unreliable, since it varies depending on the precise site at which the measurement is performed [17,18]. A study published in 2008 determined excellent inter-observer reliability for weight, height and derived BMI (r >0.99), but unsatisfactory reliability for WC (r =0.92). Only 1% of volunteers were misclassified as overweight or obese based on the BMI, whereas the use of WC led to misclassification in 6% of cases [19]. Moreover, WC is equal or inferior to BMI in predicting mortality or cardiovascular disease, according to recent data from large cohorts [9-11]. These results challenge current recommendations on obesity-related cardiovascular risk management based on WC and underscore the need for further research to improve the reliability of anthropometric measurements by physicians. In 2006, IDF recommended modifications in the definition of abnormal WC, taking into account ethnic aspects [8]. In the present study, the impact of these modifications in the relation between WC and BMI was demonstrated. Using the traditional criteria, BMI above 27 kg/m2 was the most accurate cutoff point for the prediction of abnormal WC in both genders. Interestingly, the use of the new and more stringent criteria determined that all overweight/obese subjects had abnormal WC and the most accurate cutoff point was approximately 25 kg/m2 in both men and women. This represents a controversial issue since overweight has been associated with significantly lower mortality overall relative to the normal weight category [13].

Conclusions

Based on the present findings of strong correlation with WC, BMI can reasonably be used as the first anthropometric measure to estimate adiposity since obese and the majority overweight subjects will have abnormal WC. For these patients, WC measure can be waived. For patients with a lower BMI, WC remains informative and has yet to be determined.

Abbreviations

AUC (95% CI): Area under ROC Curves with 95% confidence interval; BMI: Body mass index; IDF: International diabetes federation; R: Pearson’s correlation coefficient; ROC: Receiving operating characteristics; WC: Waist circumference.

Competing interests

The authors have no conflicts of interest and this study was not supported by any pharmaceutical company.

Authors’ contributions

MWL 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; LMPM 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; GLLM-C 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; RMdoNN 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; MMSS Have given final approval of the version to be published. AVR Have given final approval of the version to be published. All authors read and approved the final manuscript.
  18 in total

1.  A treatise on man and the development of his faculties. 1842.

Authors:  L A Quetelet
Journal:  Obes Res       Date:  1994-01

2.  Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association.

Authors:  Samuel Klein; David B Allison; Steven B Heymsfield; David E Kelley; Rudolph L Leibel; Cathy Nonas; Richard Kahn
Journal:  Diabetes Care       Date:  2007-03-14       Impact factor: 19.112

3.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 5.  Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis.

Authors:  D O Okorodudu; M F Jumean; V M Montori; A Romero-Corral; V K Somers; P J Erwin; F Lopez-Jimenez
Journal:  Int J Obes (Lond)       Date:  2010-02-02       Impact factor: 5.095

6.  Weight gain as a risk factor for clinical diabetes mellitus in women.

Authors:  G A Colditz; W C Willett; A Rotnitzky; J E Manson
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

7.  Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts.

Authors:  Amy E Taylor; Shah Ebrahim; Yoav Ben-Shlomo; Richard M Martin; Peter H Whincup; John W Yarnell; S Goya Wannamethee; Debbie A Lawlor
Journal:  Am J Clin Nutr       Date:  2010-01-20       Impact factor: 7.045

8.  Reliability of doctors' anthropometric measurements to detect obesity.

Authors:  Paul Sebo; Sigrid Beer-Borst; Dagmar M Haller; Patrick A Bovier
Journal:  Prev Med       Date:  2008-06-21       Impact factor: 4.018

9.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

Authors:  Peter W F Wilson; Ralph B D'Agostino; Lisa Sullivan; Helen Parise; William B Kannel
Journal:  Arch Intern Med       Date:  2002-09-09

Review 10.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

View more
  6 in total

1.  Engagement in New Dietary Habits-Obese Women's Experiences from Participating in a 2-Year Diet Intervention.

Authors:  Christina Ahlgren; Anne Hammarström; Susanne Sandberg; Bernt Lindahl; Tommy Olsson; Christel Larsson; Anncristine Fjellman-Wiklund
Journal:  Int J Behav Med       Date:  2016-02

2.  Serum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese population.

Authors:  Hirokazu Uemura; Sakurako Katsuura-Kamano; Miwa Yamaguchi; Fusakazu Sawachika; Kokichi Arisawa
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

3.  Association of skipping breakfast and short sleep duration with the prevalence of metabolic syndrome in the general Japanese population: Baseline data from the Japan Multi-Institutional Collaborative cohort study.

Authors:  Sakurako Katsuura-Kamano; Kokichi Arisawa; Hirokazu Uemura; Tien Van Nguyen; Toshiro Takezaki; Rie Ibusuki; Sadao Suzuki; Takahiro Otani; Rieko Okada; Yoko Kubo; Takashi Tamura; Asahi Hishida; Teruhide Koyama; Daisuke Matsui; Kiyonori Kuriki; Naoyuki Takashima; Naoko Miyagawa; Hiroaki Ikezaki; Yuji Matsumoto; Yuichiro Nishida; Chisato Shimanoe; Isao Oze; Keitaro Matsuo; Haruo Mikami; Miho Kusakabe; Kenji Takeuchi; Kenji Wakai
Journal:  Prev Med Rep       Date:  2021-10-25

4.  Assessment of adiposity in psoriatic patients by dual energy X-ray absorptiometry compared to conventional methods.

Authors:  Michelle Dos Santos Diniz; Nádia Couto Bavoso; Adriana Maria Kakehasi; Márcio Weissheimer Lauria; Maria Marta Sarquis Soares; Jackson Machado-Pinto
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

5.  Association of Dietary Acid Load with the Prevalence of Metabolic Syndrome among Participants in Baseline Survey of the Japan Multi-Institutional Collaborative Cohort Study.

Authors:  Kokichi Arisawa; Sakurako Katsuura-Kamano; Hirokazu Uemura; Nguyen Van Tien; Asahi Hishida; Takashi Tamura; Yoko Kubo; Mineko Tsukamoto; Keitaro Tanaka; Megumi Hara; Toshiro Takezaki; Daisaku Nishimoto; Teruhide Koyama; Etsuko Ozaki; Sadao Suzuki; Takeshi Nishiyama; Kiyonori Kuriki; Aya Kadota; Naoyuki Takashima; Hiroaki Ikezaki; Masayuki Murata; Isao Oze; Keitaro Matsuo; Haruo Mikami; Yohko Nakamura; Kenji Takeuchi; Kenji Wakai
Journal:  Nutrients       Date:  2020-05-29       Impact factor: 5.717

6.  Associations of Nutrient Patterns with the Prevalence of Metabolic Syndrome: Results from the Baseline Data of the Japan Multi-Institutional Collaborative Cohort Study.

Authors:  Yuki Iwasaki; Kokichi Arisawa; Sakurako Katsuura-Kamano; Hirokazu Uemura; Mineko Tsukamoto; Yuka Kadomatsu; Rieko Okada; Asahi Hishida; Keitaro Tanaka; Megumi Hara; Toshiro Takezaki; Keiichi Shimatani; Etsuko Ozaki; Teruhide Koyama; Sadao Suzuki; Hiroko Nakagawa-Senda; Kiyonori Kuriki; Naoko Miyagawa; Aya Kadota; Hiroaki Ikezaki; Norihiro Furusyo; Isao Oze; Hidemi Ito; Haruo Mikami; Yohko Nakamura; Kenji Wakai
Journal:  Nutrients       Date:  2019-04-30       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.